These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18357992)

  • 1. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
    Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
    Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of high-amylose starch tablets. 3. Initial diffusion and temperature effects.
    Thérien-Aubin H; Baille WE; Zhu XX; Marchessault RH
    Biomacromolecules; 2005; 6(6):3367-72. PubMed ID: 16283767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR imaging of chitosan and carboxymethyl starch tablets: swelling and hydration of the polyelectrolyte complex.
    Wang YJ; Assaad E; Ispas-Szabo P; Mateescu MA; Zhu XX
    Int J Pharm; 2011 Oct; 419(1-2):215-21. PubMed ID: 21864660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted amylose matrices for oral drug delivery.
    Moghadam SH; Wang HW; Saddar El-Leithy E; Chebli C; Cartilier L
    Biomed Mater; 2007 Mar; 2(1):S71-7. PubMed ID: 18458424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
    Mulhbacher J; Ispas-Szabo P; Mateescu MA
    Int J Pharm; 2004 Jul; 278(2):231-8. PubMed ID: 15196628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
    Lemieux M; Gosselin P; Mateescu MA
    Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets.
    Onofre FO; Wang YJ
    Int J Pharm; 2010 Jan; 385(1-2):104-12. PubMed ID: 19879935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of hydration of cross-linked high amylose starch by solid state 13C NMR spectroscopy.
    Thérien-Aubin H; Janvier F; Baille WE; Zhu XX; Marchessault RH
    Carbohydr Res; 2007 Aug; 342(11):1525-9. PubMed ID: 17509547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive properties of cross-linked high amylose starch derivatives.
    Mulhbacher J; Ispas-Szabo P; Ouellet M; Alex S; Mateescu MA
    Int J Biol Macromol; 2006 Dec; 40(1):9-14. PubMed ID: 16837041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process.
    Brouillet F; Baylac G; Cartilier L; Bataille B
    Drug Dev Ind Pharm; 2010 Jul; 36(7):795-805. PubMed ID: 20136492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR imaging of high-amylose starch tablets. 1. Swelling and water uptake.
    Baille WE; Malveau C; Zhu XX; Marchessault RH
    Biomacromolecules; 2002; 3(1):214-8. PubMed ID: 11866576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM; Takezoe K; Yamaura K
    Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linked high amylose starch for controlled release of drugs: recent advances.
    Lenaerts V; Moussa I; Dumoulin Y; Mebsout F; Chouinard F; Szabo P; Mateescu MA; Cartilier L; Marchessault R
    J Control Release; 1998 Apr; 53(1-3):225-34. PubMed ID: 9741930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
    Nabais T; Zaraa S; Leclair G
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1887-93. PubMed ID: 27109692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release.
    Prado HJ; Matulewicz MC; Bonelli PR; Cukierman AL
    Carbohydr Res; 2009 Jul; 344(11):1325-31. PubMed ID: 19539898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
    Dahlberg C; Fureby A; Schuleit M; Dvinskikh SV; Furó I
    J Control Release; 2007 Sep; 122(2):199-205. PubMed ID: 17706829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
    Assaad E; Mateescu MA
    Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling a system of phosphated cross-linked high amylose for controlled drug release. Part 2: physical parameters, cross-linking degrees and drug delivery relationships.
    Cury BS; Castro AD; Klein SI; Evangelista RC
    Int J Pharm; 2009 Apr; 371(1-2):8-15. PubMed ID: 19124066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.